These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8335169)

  • 1. Tolbutamide reduces the incidence of diabetes mellitus, but not insulitis, in the non-obese-diabetic mouse.
    Williams AJ; Beales PE; Krug J; Procaccini E; Signore A; Xu S; Gale EA; Pozzilli P
    Diabetologia; 1993 Jun; 36(6):487-92. PubMed ID: 8335169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First phase insulin release in the non-obese diabetic mouse: correlation with insulitis, beta cell number and autoantibodies.
    Reddy S; Liu W; Thompson JM; Bibby NJ; Elliott RB
    Diabetes Res Clin Pract; 1992 Jul; 17(1):17-25. PubMed ID: 1511657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor I (IGF-I) delays the onset of diabetes in non-obese diabetic (NOD) mice.
    Kaino Y; Hirai H; Ito T; Kida K
    Diabetes Res Clin Pract; 1996 Sep; 34(1):7-11. PubMed ID: 8968685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenografts of porcine islets immunoprotected in hollow fibres reduce the incidence of diabetes in non-obese diabetic mice.
    Chaillous L; Darquy S; Maugendre S; Rivereau AS; Reach G; Saï P
    Diabetologia; 1996 May; 39(5):523-9. PubMed ID: 8739911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical enhancement of tolbutamide-induced insulin release by diazoxide in a patient with islet cell hyperplasia.
    Schikman CH; Chertow BS; Fariss BL
    Acta Paediatr Scand; 1978 Sep; 67(5):671-6. PubMed ID: 358739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice.
    Yang ZD; Chen M; Wu R; McDuffie M; Nadler JL
    Diabetologia; 2002 Sep; 45(9):1307-14. PubMed ID: 12242464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue of beta-cell exhaustion by diazoxide after the development of diabetes mellitus in rats with streptozotocin-induced diabetes.
    Matsuda M; Kawasaki F; Mikami Y; Takeuchi Y; Saito M; Eto M; Kaku K
    Eur J Pharmacol; 2002 Oct; 453(1):141-8. PubMed ID: 12393069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lazaroid antioxidant reduces incidence of diabetes and insulitis in nonobese diabetic mice.
    Rabinovitch A; Suarez WL; Power RF
    J Lab Clin Med; 1993 Apr; 121(4):603-7. PubMed ID: 8454942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolbutamide and diazoxide influence insulin secretion by changing the concentration but not the action of cytoplasmic Ca2+ in beta-cells.
    Mariot P; Gilon P; Nenquin M; Henquin JC
    Diabetes; 1998 Mar; 47(3):365-73. PubMed ID: 9519741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin does not alter diabetes incidence in the NOD mouse.
    Beales PE; Giorgini A; Annovazzi A; Signore A; Parlapiano C; Pozzilli P
    Horm Metab Res; 1997 Jun; 29(6):261-3. PubMed ID: 9230345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolbutamide and diazoxide modulate phospholipase C-linked Ca(2+) signaling and insulin secretion in beta-cells.
    Schöfl C; Börger J; Mader T; Waring M; von zur Mühlen A; Brabant G
    Am J Physiol Endocrinol Metab; 2000 Apr; 278(4):E639-47. PubMed ID: 10751197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taurine supplement in early life altered islet morphology, decreased insulitis and delayed the onset of diabetes in non-obese diabetic mice.
    Arany E; Strutt B; Romanus P; Remacle C; Reusens B; Hill DJ
    Diabetologia; 2004 Oct; 47(10):1831-7. PubMed ID: 15502919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recombinant human IGF-1 prevents type 1 diabetes in female non-obese diabetic mice].
    Liu F; Yu M; Zhu Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Sep; 34(5):281-3. PubMed ID: 11372396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite effects of tolbutamide and diazoxide on 86Rb+ fluxes and membrane potential in pancreatic B cells.
    Henquin JC; Meissner HP
    Biochem Pharmacol; 1982 Apr; 31(7):1407-15. PubMed ID: 7046755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early nicotinamide treatment in the NOD mouse: effects on diabetes and insulitis suppression and autoantibody levels.
    Reddy S; Bibby NJ; Elliott RB
    Diabetes Res; 1990 Oct; 15(2):95-102. PubMed ID: 2151892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Tenidap, a novel anti-inflammatory compound on islet lymphocytic infiltration and diabetes incidence in the non obese diabetic (NOD) mouse.
    Beales PE; Williams A; Krug J; Signore A; Chianelli M; Andreani D; Pozzilli P
    Diabete Metab; 1992; 18(1):48-53. PubMed ID: 1563537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous glucose intolerance in the progeny of low dose streptozotocin-induced diabetic mice.
    Linn T; Loewk E; Schneider K; Federlin K
    Diabetologia; 1993 Dec; 36(12):1245-51. PubMed ID: 8307251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
    Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S
    Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of BCG, lymphotoxin and bee venom on insulitis and development of IDDM in non-obese diabetic mice.
    Kim JY; Cho SH; Kim YW; Jang EC; Park SY; Kim EJ; Lee SK
    J Korean Med Sci; 1999 Dec; 14(6):648-52. PubMed ID: 10642943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae.
    Saï P; Rivereau AS
    Diabetes Metab; 1996 Oct; 22(5):341-8. PubMed ID: 8896996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.